Researchers have designed novel experimental drugs namely, Thiostrepton, whose pharmacological action consists of targeting the sonic Hedgehog signaling, Thiostrepton suppresses the population of CD44+/CD24− cancer stem cells (CSCs) of TNBC cell lines [42]. Here, CD44 is linked to cancer.